speb/financial-data huggingface dataset:
CPRX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 11000.00
CPRX balance_sheet (annual, 2024-12-31) — Payables: 21069000.00
CPRX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 109113000.00
CPRX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10746000.00
CPRX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CPRX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 19998000.00
CPRX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 19998000.00
CPRX income_statement (annual, 2024-12-31) — Pretax Income: 216263000.00
CPRX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 13515000.00
CPRX balance_sheet (annual, 2024-12-31) — Properties: 0.00
CPRX cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
CPRX cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
CPRX cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
CPRX cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
CPRX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -556000.00
CPRX balance_sheet (annual, 2024-12-31) — Raw Materials: 6518000.00
CPRX balance_sheet (annual, 2024-12-31) — Receivables: 66012000.00
CPRX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 68448000.00
CPRX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 37774000.00
CPRX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CPRX income_statement (annual, 2024-12-31) — Research And Development: 12648000.00
CPRX balance_sheet (annual, 2024-12-31) — Retained Earnings: 285161000.00
CPRX income_statement (annual, 2024-12-31) — Salaries And Wages: 20472000.00
CPRX cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
CPRX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 111344000.00
CPRX income_statement (annual, 2024-12-31) — Selling General And Administration: 177740000.00
CPRX balance_sheet (annual, 2024-12-31) — Share Issued: 120879099.00
CPRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 22251000.00
CPRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 727632000.00
CPRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 570960000.00
CPRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1228150.00
CPRX income_statement (annual, 2024-12-31) — Tax Provision: 52374000.00
CPRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.24
CPRX balance_sheet (annual, 2024-12-31) — Total Assets: 851411000.00
CPRX balance_sheet (annual, 2024-12-31) — Total Capitalization: 727632000.00
CPRX balance_sheet (annual, 2024-12-31) — Total Debt: 3188000.00
CPRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 727632000.00
CPRX income_statement (annual, 2024-12-31) — Total Expenses: 296610000.00
CPRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 123779000.00
CPRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 227802000.00
CPRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3101000.00
CPRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 195124000.00
CPRX income_statement (annual, 2024-12-31) — Total Other Finance Cost: -16064000.00
CPRX income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -4616000.00
CPRX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 894000.00
CPRX income_statement (annual, 2024-12-31) — Total Unusual Items: 5075000.00
CPRX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 5075000.00
CPRX balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
CPRX balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
CPRX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -5075000.00
CPRX balance_sheet (annual, 2024-12-31) — Work In Process: 3445000.00
CPRX balance_sheet (annual, 2024-12-31) — Working Capital: 502931000.00
CPRX income_statement (quarterly, 2025-03-31) — +Operating Expense: 60143000.00
CPRX income_statement (quarterly, 2025-03-31) — +Total Revenue: 141421000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 11197000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 71265000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 972000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1235000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 452280000.00
CPRX income_statement (quarterly, 2025-03-31) — Amortization: 9345000.00
CPRX cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 9345000.00
CPRX cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 9345000.00
CPRX income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 9345000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 24208000.00
CPRX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 121472468.00
CPRX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.47
CPRX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 517553000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3091000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 122000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 580656000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 580656000.00
CPRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3060000.00
CPRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
CPRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 60043000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -5396000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2552000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -237000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -97000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Payable: -5396000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -7948000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 7020000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -5789000.00
CPRX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -7051000.00
CPRX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -5789000.00
CPRX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 63103000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Common Stock: 122000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 794283000.00
CPRX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CPRX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CPRX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 17911000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 77628000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Current Assets: 685718000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 410000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 410000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 111649000.00
CPRX cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -2321000.00
CPRX cash_flow (quarterly, 2025-03-31) — Deferred Tax: -2321000.00
CPRX cash_flow (quarterly, 2025-03-31) — Depreciation: 115000.00
CPRX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 9460000.00
CPRX income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 9345000.00
CPRX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 9460000.00
CPRX income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 9345000.00
CPRX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 126957982.00
CPRX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.45
CPRX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 56737000.00
CPRX income_statement (quarterly, 2025-03-31) — EBIT: 63367000.00
CPRX income_statement (quarterly, 2025-03-31) — EBITDA: 72827000.00
CPRX cash_flow (quarterly, 2025-03-31) — End Cash Position: 580656000.00
CPRX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3060000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 8119000.00
CPRX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 60043000.00
CPRX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 2644000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -17000.00
CPRX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 17010000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 147327000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4632000.00
CPRX income_statement (quarterly, 2025-03-31) — Gross Profit: 123510000.00
CPRX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 639000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 11087000.00
CPRX income_statement (quarterly, 2025-03-31) — Interest Income: 5275000.00
CPRX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 5275000.00
CPRX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 103000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Interest Payable: 425000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Inventory: 19778000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 794283000.00
CPRX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
CPRX balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 24208000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 24208000.00
CPRX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CPRX balance_sheet (quarterly, 2025-03-31) — Leases: 991000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2681000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2681000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1483000.00
CPRX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CPRX income_statement (quarterly, 2025-03-31) — Net Income: 56737000.00
CPRX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 56737000.00
CPRX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 56737000.00
CPRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 56737000.00
CPRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 56737000.00
CPRX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 56737000.00
CPRX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 56737000.00
CPRX income_statement (quarterly, 2025-03-31) — Net Interest Income: 5275000.00
CPRX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 5275000.00
CPRX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1727000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Net PPE: 3397000.00
CPRX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
CPRX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 646956000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 48222000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 48222000.00
CPRX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 70183000.00
CPRX income_statement (quarterly, 2025-03-31) — Normalized Income: 54632622.87
CPRX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 60043000.00
CPRX income_statement (quarterly, 2025-03-31) — Operating Income: 63367000.00
CPRX income_statement (quarterly, 2025-03-31) — Operating Revenue: 141421000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 121959172.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 452000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2225000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -17000.00
CPRX income_statement (quarterly, 2025-03-31) — Other Gand A: 11585000.00
CPRX income_statement (quarterly, 2025-03-31) — Other Income Expense: 2644000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 147327000.00
CPRX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 12000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 259000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Payable: 2497000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Properties: 2158000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 21000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Payables: 24781000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 102409000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6605000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CPRX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 12574000.00
CPRX income_statement (quarterly, 2025-03-31) — Pretax Income: 71286000.00
CPRX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 4787000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CPRX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
CPRX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 7435000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Receivables: 72258000.00
CPRX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 17796000.00
CPRX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 9460000.00
CPRX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CPRX income_statement (quarterly, 2025-03-31) — Research And Development: 3887000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 341898000.00
CPRX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5425000.00
CPRX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 29901000.00
CPRX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 46911000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Share Issued: 121959172.00
CPRX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 5850000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 794283000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 646956000.00
CPRX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 539622.87
CPRX income_statement (quarterly, 2025-03-31) — Tax Provision: 14549000.00
CPRX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.20
CPRX balance_sheet (quarterly, 2025-03-31) — Total Assets: 908872000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 794283000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Total Debt: 3091000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 794283000.00
CPRX income_statement (quarterly, 2025-03-31) — Total Expenses: 78054000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 114589000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 223154000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2940000.00
CPRX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 63367000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 11087000.00
CPRX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 2644000.00
CPRX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 2644000.00
CPRX cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -2644000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Work In Process: 4224000.00
CPRX balance_sheet (quarterly, 2025-03-31) — Working Capital: 574069000.00
CPRX income_statement (quarterly, 2025-06-30) — +Operating Expense: 59651000.00
CPRX income_statement (quarterly, 2025-06-30) — +Total Revenue: 146563000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5528000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 65863000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 427000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1351000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 461868000.00
CPRX income_statement (quarterly, 2025-06-30) — Amortization: 9344000.00
CPRX cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 9344000.00
CPRX cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 9344000.00
CPRX income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 9344000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 21256000.00
CPRX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 122163212.00
CPRX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.43
CPRX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 580656000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2991000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 122000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 652800000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 652800000.00
CPRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 872000.00
CPRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -26000.00
CPRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 71298000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -5669000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 8265000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 455000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -100000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Payable: -5669000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 2596000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -7407000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 5402000.00
CPRX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 946000.00
CPRX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 5402000.00
CPRX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 72144000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 122000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 856027000.00
CPRX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CPRX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CPRX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 20614000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 95059000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 758739000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 419000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 419000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 113007000.00
CPRX cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2434000.00
CPRX cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2434000.00
CPRX cash_flow (quarterly, 2025-06-30) — Depreciation: 116000.00
CPRX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 9460000.00
CPRX income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 9344000.00
CPRX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 9460000.00
CPRX income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 9344000.00
CPRX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 127543284.00
CPRX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.41
CPRX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 52108000.00
CPRX income_statement (quarterly, 2025-06-30) — EBIT: 66298000.00
CPRX income_statement (quarterly, 2025-06-30) — EBITDA: 75758000.00
CPRX cash_flow (quarterly, 2025-06-30) — End Cash Position: 652800000.00
CPRX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 872000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 8119000.00
CPRX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 71272000.00
CPRX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -2952000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 31000.00
CPRX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 17665000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 137983000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4584000.00
CPRX income_statement (quarterly, 2025-06-30) — Gross Profit: 125949000.00
CPRX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 38601000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 439000.00
CPRX income_statement (quarterly, 2025-06-30) — Interest Income: 5947000.00
CPRX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 5947000.00
CPRX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 112000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Interest Payable: 347000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Inventory: 18650000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 856027000.00
CPRX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -26000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 21256000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 21256000.00
CPRX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CPRX balance_sheet (quarterly, 2025-06-30) — Leases: 991000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2572000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2572000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 1509000.00
CPRX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CPRX income_statement (quarterly, 2025-06-30) — Net Income: 52108000.00
CPRX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 52108000.00
CPRX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 52108000.00
CPRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 52108000.00
CPRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 52108000.00
CPRX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 52108000.00
CPRX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 52108000.00
CPRX income_statement (quarterly, 2025-06-30) — Net Interest Income: 5947000.00
CPRX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 5947000.00
CPRX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1338000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Net PPE: 3233000.00
CPRX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -26000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 718044000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 50704000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 50704000.00
CPRX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 78710000.00
CPRX income_statement (quarterly, 2025-06-30) — Normalized Income: 54327889.69
CPRX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 71298000.00
CPRX income_statement (quarterly, 2025-06-30) — Operating Income: 66298000.00
CPRX income_statement (quarterly, 2025-06-30) — Operating Revenue: 146563000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 122385569.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1243000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 747000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 31000.00
CPRX income_statement (quarterly, 2025-06-30) — Other Gand A: 10972000.00
CPRX income_statement (quarterly, 2025-06-30) — Other Income Expense: -2952000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 137983000.00
CPRX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -4000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 309000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Payable: 1378000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Properties: 2084000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 23000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Payables: 7345000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 102404000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 9437000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CPRX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 19733000.00
CPRX income_statement (quarterly, 2025-06-30) — Pretax Income: 69293000.00
CPRX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 2210000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CPRX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -26000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 5186000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Receivables: 66313000.00
CPRX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 20498000.00
CPRX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 9460000.00
CPRX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CPRX income_statement (quarterly, 2025-06-30) — Research And Development: 4358000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 394006000.00
CPRX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 6693000.00
CPRX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 28284000.00
CPRX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 45949000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 121959172.00
CPRX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7597000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 856027000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 718044000.00
CPRX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -732110.31
CPRX income_statement (quarterly, 2025-06-30) — Tax Provision: 17185000.00
CPRX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
CPRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 971915000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 856027000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 2991000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 856027000.00
CPRX income_statement (quarterly, 2025-06-30) — Total Expenses: 80265000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 115888000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 213176000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2881000.00
CPRX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 66298000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 439000.00
CPRX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -2952000.00
CPRX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -2952000.00
CPRX cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 2952000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Work In Process: 5345000.00
CPRX balance_sheet (quarterly, 2025-06-30) — Working Capital: 645732000.00
CPRX income_statement (quarterly, 2025-09-30) — +Operating Expense: 59471000.00
CPRX income_statement (quarterly, 2025-09-30) — +Total Revenue: 148392000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 9096000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 106409000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 360000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1423000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 473333000.00
CPRX income_statement (quarterly, 2025-09-30) — Amortization: 9344000.00
CPRX cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 9344000.00
CPRX cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 9344000.00
CPRX income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 9344000.00
CPRX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -292000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 19167000.00
CPRX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 122600730.00
CPRX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.43
CPRX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 652800000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2889000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 123000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 689892000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 689892000.00
CPRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 4654000.00
CPRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
CPRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 32438000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 3568000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 13241000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -9087000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -102000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Payable: 3568000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 16809000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -6697000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -40546000.00
CPRX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -39623000.00
CPRX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -40546000.00
CPRX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 37092000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Common Stock: 123000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 920245000.00
CPRX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CPRX cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CPRX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 22654000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 105982000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Current Assets: 852453000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 428000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 428000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 128735000.00
CPRX cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 2417000.00
CPRX cash_flow (quarterly, 2025-09-30) — Deferred Tax: 2417000.00
CPRX cash_flow (quarterly, 2025-09-30) — Depreciation: 72000.00
CPRX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 9416000.00
CPRX income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 9344000.00
CPRX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 9416000.00
CPRX income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 9344000.00
CPRX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 127090194.00
CPRX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.42
CPRX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 52783000.00
CPRX income_statement (quarterly, 2025-09-30) — EBIT: 66267000.00
CPRX income_statement (quarterly, 2025-09-30) — EBITDA: 75683000.00
CPRX cash_flow (quarterly, 2025-09-30) — End Cash Position: 689892000.00
CPRX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 4654000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Finished Goods: 11292000.00
CPRX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 32438000.00
CPRX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -2089000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 0.00
CPRX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 17013000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 128639000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4510000.00
CPRX income_statement (quarterly, 2025-09-30) — Gross Profit: 125738000.00
CPRX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 15895000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 710000.00
CPRX income_statement (quarterly, 2025-09-30) — Interest Income: 6857000.00
CPRX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 6857000.00
CPRX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 121000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Interest Payable: 251000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Inventory: 28029000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 920245000.00
CPRX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
CPRX balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 19167000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 19167000.00
CPRX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CPRX balance_sheet (quarterly, 2025-09-30) — Leases: 991000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2461000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2461000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 1509000.00
CPRX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CPRX income_statement (quarterly, 2025-09-30) — Net Income: 52783000.00
CPRX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 52783000.00
CPRX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 52783000.00
CPRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 52783000.00
CPRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 52783000.00
CPRX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 52783000.00
CPRX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 52783000.00
CPRX income_statement (quarterly, 2025-09-30) — Net Interest Income: 6857000.00
CPRX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 6857000.00
CPRX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1142000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Net PPE: 3087000.00
CPRX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
CPRX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 791606000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 48256000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 48256000.00
CPRX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 77772000.00
CPRX income_statement (quarterly, 2025-09-30) — Normalized Income: 54335244.49
CPRX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 32438000.00
CPRX income_statement (quarterly, 2025-09-30) — Operating Income: 66267000.00
CPRX income_statement (quarterly, 2025-09-30) — Operating Revenue: 148392000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 123264583.00
CPRX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3504000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 842000.00
CPRX income_statement (quarterly, 2025-09-30) — Other Gand A: 11753000.00
CPRX income_statement (quarterly, 2025-09-30) — Other Income Expense: -2089000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 128639000.00
CPRX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -22000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 161000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Other Payable: 1104000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Other Properties: 2010000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 26000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Payables: 10910000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 116892000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 10573000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CPRX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 24233000.00
CPRX income_statement (quarterly, 2025-09-30) — Pretax Income: 71035000.00
CPRX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 5796000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CPRX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
CPRX balance_sheet (quarterly, 2025-09-30) — Raw Materials: 12139000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Receivables: 106795000.00
CPRX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 22582000.00
CPRX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 9416000.00
CPRX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CPRX income_statement (quarterly, 2025-09-30) — Research And Development: 2657000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 446789000.00
CPRX income_statement (quarterly, 2025-09-30) — Salaries And Wages: 5260000.00
CPRX income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 30457000.00
CPRX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 47470000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Share Issued: 123264583.00
CPRX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5670000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 920245000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 791606000.00
CPRX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -536755.51
CPRX income_statement (quarterly, 2025-09-30) — Tax Provision: 18252000.00
CPRX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
CPRX balance_sheet (quarterly, 2025-09-30) — Total Assets: 1051602000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 920245000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Total Debt: 2889000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 920245000.00
CPRX income_statement (quarterly, 2025-09-30) — Total Expenses: 82125000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 131357000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 199149000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2622000.00
CPRX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 66267000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 710000.00
CPRX income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2089000.00
CPRX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2089000.00
CPRX cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 2089000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Work In Process: 4598000.00
CPRX balance_sheet (quarterly, 2025-09-30) — Working Capital: 723718000.00
CPRX income_statement (annual, 2025-12-31) — +Operating Expense: 243958000.00
CPRX income_statement (quarterly, 2025-12-31) — +Operating Expense: 64693000.00
CPRX income_statement (annual, 2025-12-31) — +Total Revenue: 588989000.00
CPRX income_statement (quarterly, 2025-12-31) — +Total Revenue: 152613000.00
CPRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 11202000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 11202000.00
CPRX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 126477000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 126477000.00
CPRX balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 1789000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 1789000.00
CPRX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1495000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1495000.00
CPRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 479957000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 479957000.00
CPRX income_statement (annual, 2025-12-31) — Amortization: 37498000.00
CPRX income_statement (quarterly, 2025-12-31) — Amortization: 9465000.00
CPRX cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 37498000.00
CPRX cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 9465000.00
CPRX cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 37498000.00
CPRX cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 9465000.00
CPRX income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 37498000.00
CPRX income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 9465000.00
CPRX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 464000.00
CPRX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 83000.00
CPRX income_statement (annual, 2025-12-31) — Basic Average Shares: 122290866.00
CPRX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 122907933.00
CPRX income_statement (annual, 2025-12-31) — Basic EPS: 1.75
CPRX income_statement (quarterly, 2025-12-31) — Basic EPS: 0.43
CPRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 517553000.00
CPRX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 689892000.00
CPRX cash_flow (annual, 2025-12-31) — Capital Expenditure: -58000.00
CPRX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -32000.00
CPRX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2787000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2787000.00
CPRX balance_sheet (annual, 2025-12-31) — Capital Stock: 123000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 123000.00
CPRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 709171000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 709171000.00
CPRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 709171000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 709171000.00
CPRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -16994000.00
CPRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -25580000.00
CPRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -58000.00
CPRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -32000.00
CPRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 208670000.00
CPRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 44891000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Account Payable: -5391000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2106000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 24164000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 5210000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Inventory: -18089000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -9220000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -401000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -102000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Payable: -5391000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Payable: 2106000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 18773000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 7316000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -177000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 6907000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Receivables: -61001000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -20068000.00
CPRX cash_flow (annual, 2025-12-31) — Change In Working Capital: -60895000.00
CPRX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -15167000.00
CPRX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -61001000.00
CPRX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -20068000.00
CPRX cash_flow (annual, 2025-12-31) — Changes In Cash: 191618000.00
CPRX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 19279000.00
CPRX balance_sheet (annual, 2025-12-31) — Common Stock: 123000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 123000.00
CPRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 954268000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 954268000.00
CPRX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CPRX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CPRX cash_flow (annual, 2025-12-31) — Common Stock Payments: -25300000.00
CPRX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -25300000.00
CPRX income_statement (annual, 2025-12-31) — Cost Of Revenue: 87253000.00
CPRX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 26074000.00
CPRX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 108120000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 108120000.00
CPRX balance_sheet (annual, 2025-12-31) — Current Assets: 894030000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Current Assets: 894030000.00
CPRX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 437000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 437000.00
CPRX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 437000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 437000.00